Literatur
-
1
Antcliff R J, Spalton D J, Stanford M R. et al .
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.
Ophthalmology.
2001;
108
765-772
-
2
Antonetti D A, Barber A J, Khin S. et al .
Vascular permeability in experimental diabetes associated with reduced endothelial occluding content.
Diabetes.
1998;
47
1953-1959
-
3
Bresnik G H.
Diabetic maculopathy. A clinical review highlighting diffuse macular edema.
Ophthalmology.
1983;
90
1301-1317
-
4
Brooks Jr H L, Caballero Jr S, Newell C K. et al .
Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
Arch Ophthalmol.
2004;
122
1801-1807
-
5
Capone Jr A, Panozzo G.
Vitrectomy for refractory diabetic macular edema.
Semin Ophthalmol.
2000;
15
78-80
-
6
Charles S, Flinn C E.
The natural history of extramacular tractional detachment.
Arch Ophthalmol.
1979;
97
1268-1272
-
7
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group .
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy.
New Engl J Med.
2000;
342
381-389
-
8
Diabetic Retinopathy Vitrectomy Study Research Group .
Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision: results of a randomized trial. DRVS Report 3.
Ophthalmology.
1988;
95
1307-1320
-
9
Diabetic Retinopathy Vitrectomy Study Research Group .
Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two year results of a randomized trial. DRVS Report 2.
Arch Ophthalmol.
1985;
103
1644-1652
-
10
Diabetic Retinopathy Study Research Group .
Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of diabetic retinopathy study (DRS) findings. DRS Report 8.
Ophthalmology.
1981;
88
583-600
-
11
Diabetic Retinopathy Study Research Group .
Four risk factors for severe visual loss in diabetic retinopathy: DRS Report 3.
Arch Ophthalmol.
1979;
97
654-655
-
12
Early Treatment Diabetic Retinopathy Study Research Group .
Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. ETDRS Report 20.
Arch Ophthalmol.
1995;
113
52-55
-
13
Early Treatment Diabetic Retinopathy Study Research Group .
Early photocoagulation for diabetic retinopathy. ETDRS Report 9.
Ophthalmology.
1991;
98
766-785
-
14
Early Treatment Diabetic Retinopathy Study Research Group .
Photocoagulation for diabetic macular edema.
Arch Ophthalmol.
1985;
103
1796-1806
-
15
Ferrari T M, Cardascia N, Durante G.
Pars plana vitrectomy in diabetic macular edema.
Doc Ophthalmol.
1999;
97
267-270
-
16
Flynn Jr H W, Chew E Y, Simons B D.
Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group.
Ophthalmology.
1992;
99
1351-1357
-
17
Gandorfer A, Messmer E M, Ulbig M W, Kampik A.
Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.
Retina.
2000;
20
126-133
-
18
Harbour J W, Smiddy W E, Flynn H W, Rubsamen P E.
Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane.
Am J Ophthalmol.
1996;
121
405-413
-
19
Haritoglou C, Gandorfer A, Gass C A.
Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation.
Am J Ophthalmol.
2002;
134
836-841
-
20
Haritoglou C, Gass C A, Schaumberger M.
Macular changes after peeling of the internal limiting membrane in macular hole surgery.
Am J Ophthalmol.
2001;
132
363-369
-
21
Harris M I.
Diabetes in America: epidemiology and scope of the problem.
Diabetes Care.
1998;
21
C11-14
-
22
Helbig H, Kellner U, Bornfeld N, Foerster M H.
Vitrectomy in diabetic retinopathy: outcome, risk factors, complications.
Klin Monatsbl Augenheilkd.
1998;
212
339-342
-
23
Helbig H, Kellner U, Bornfeld N, Foerster M H.
Limits and possibilities of vitreous body surgery in diabetic retinopathy.
Ophthalmologe.
1996;
93
647-654
-
24
Hikichi T, Fujio N, Akiba Y, Takahashi M, Yoshida A.
Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus.
Ophthalmology.
1997;
104
473-478
-
25
Ho T, Smiddy W E, Flynn Jr H W.
Vitrectomy in the management of diabetic eye disease.
Surv Ophthalmol.
1992;
37
190-202
-
26
Jonas J B, Akkoyun I, Kreissig I, Degenring R F.
Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.
Br J Ophthalmol.
2005;
89
321-326
-
27
Jonas J B, Degenring R F, Kamppeter B A. et al .
Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
Am J Ophthalmol.
2004;
138
158-160
-
28
Jonas J B, Hayler J K, Sofker A, Panda-Jonas S.
Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy.
Am J Ophthalmol.
2001;
131
468-471
-
29
Jonas J B, Sofker A.
Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.
Am J Ophthalmol.
2001;
132
425-427
-
30
Kaiser P K, Riemann C D, Sears J E, Lewis H.
Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction.
Am J Ophthalmol.
2001;
131
44-49
-
31
Klein R, Klein B EK, Moss S E.
Visual impairment in diabetes.
Ophthalmology.
1984;
91
1-8
-
32
Klein R, Klein B EK, Moss S E, Cruickshanks K J.
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.
Ophthalmology.
1998;
105
1801-1815
-
33
Klein R, Klein B EK, Moss S E, Davis M D, DeMets D L.
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.
Arch Ophthalmol.
1984;
102
520-526
-
34
Klein R, Klein B E, Moss S E, Davis M D, DeMets D L.
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.
Arch Ophthalmol.
1984;
102
527-532
-
35
La Heij E C, Hebdrikse F, Kessels A GH, Derhaag P JFM.
Vitrectomy results in diabetic macular oedema without evident vitreomacular traction.
Graefe's Arch Clin Exp Ophthalmol.
2001;
239
264-270
-
36
Lewis H.
The role of vitrectomy in the treatment of diabetic macular edema.
Am J Ophthalmol.
2001;
131
123-125
-
37
Lewis H, Abrams G W, Blumenkranz M S, Campo R.
Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction.
Ophthalmology.
1992;
99
753-759
-
38
Lopes de Faria J M, Jalkh A E, Trempe C L, McMeel J W.
Diabetic macular edema: risk factors and concomitants.
Acta Ophthalmol Scand.
1999;
77
170-175
-
39
Martidis A, Duker J S, Greenberg P B, Rogers A H. et al .
Intravitreal triamcinolone for refractory diabetic macular edema.
Ophthalmology.
2002;
109
920-927
-
40
Massin P, Audren F, Haouchine B, Erginay A, Bergmann J F, Benosman R, Caulin C, Gaudric A.
Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
Ophthalmology.
2004;
111
218-224
-
41
Nasrallah F P, Jalkh A E, VanCoppenrolle, Kado M, Trempe C L, McMeel J W, Schepens C L.
The role of the vitreous in diabetic macular edema.
Ophthalmology.
1988;
95
1335-1339
-
42
Oldendoerp J, Spitznas M.
Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus.
Graefes Arch Clin Exp Ophthalmol.
1989;
227
1-8
-
43
Pendergast S D, Hassan T S, Williams, Cox M S. et al .
Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.
Am J Ophthalmol.
2000;
130
178-186
-
44
Sato Y, Lee Z, Shimada H.
Vitrectomy for diabetic cystoid macular edema.
Nippon Ganka Gakkai Zasshi.
2001;
105
251-256
-
45
Stefansson E, Novack R L, Hatchell D L.
Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion.
Invest Ophthalmol Vis Sci.
1990;
31
284-289
-
46
Sutter F K, Simpson J M, Gillies M C.
Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Ophthalmology.
2004;
111
2044-2049
-
47
Tachi N, Ogina N.
Vitrectomy for diffuse macular edema in cases of diabetic retinopathy.
Am J Ophthalmol.
1996;
122
258-260
-
48
Ulbig M, Kampik A, Heidenkummer H P.
Vitrectomy in proliferative diabetic retinopathy. Preoperative factors for surgical procedure and postoperative results.
Fortschr Ophthalmol.
1990;
87
443-448
-
49
Ulbig M W, Mangouritsas G, Rothbacher H H, Hamilton A M, McHugh J D.
Long-term results after drainage of premacular subhyaloid hemorrhage into the vitreous with a pulsed Nd:YAG laser.
Arch Ophthalmol.
1998;
116
1465-1469
-
50
Weinberger D, Fink-Cohen S, Gaton. et al .
Non-retinovascular leakage in diabetic maculopathy.
Br J Ophthalmol.
1995;
79
728-731
-
51
Yamamoto T, Naoko A, Takeuchi S.
Vitrectomy for diabetic macular edema: The role of posterior vitreous detachment and epimacular membrane.
Am J Ophthalmol.
2001;
132
369-377
-
52
Yang C M.
Surgical treatment for severe macular edema with massive hard exsudates.
Retina.
2000;
20
121-125
-
53
Zacks D N, Johnson M W.
Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy.
Retina.
2005;
25
135-140
PD Dr. Christos Haritoglou
Augenklinik der Ludwig-Maximilians-Universität
Mathildenstraße 8
80336 München
eMail: christos.haritoglou@med.uni-muenchen.de
